The demo will be fully sourced from a $3.2 million Department of Development grant received last summer, Roberts confirmed.
For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback